Talazoparib
Showing 51 - 75 of 107
Squamous Cell Carcinoma of the Head and Neck (SCCHN), Metastatic Castration Resistant Prostate Cancer (mCRPC) Trial in Worldwide
Terminated
- Squamous Cell Carcinoma of the Head and Neck (SCCHN)
- Metastatic Castration Resistant Prostate Cancer (mCRPC)
- avelumab
- +3 more
-
Rochester, New York
- +4 more
Sep 17, 2021
Kinase Inhibitor Targeted Therapies
Not yet recruiting
- Blood Concentrations of Nine Anti-cancer Drugs : Axitinib, Olaparib, regorafénib, Cabozantinib, Niraparib, Talazoparib, Palbociclib, Abemaciclib, Tucatinib
- Measurement of drug concentrations
-
Rennes, France
- +2 more
Nov 7, 2022
Advanced Malignant Solid Tumor, Clinical Stage III Gastroesophageal Junction Adenocarcinoma, Clinical Stage IV Gastroesophageal
Recruiting
- Advanced Malignant Solid Neoplasm
- +28 more
- Trifluridine and Tipiracil Hydrochloride
- Talazoparib Tosylate
-
Buffalo, New YorkRoswell Park Cancer Institute
Mar 2, 2022
Pancreatic Cancer Trial in Belgium, Singapore, United States (Avelumab, Binimetinib, Talazoparib)
Cancer, Advanced Solid Tumor Trial in Kettering (lorlatinib, encorafenib + binimetinib, talazoparib)
Recruiting
- Cancer
- Advanced Solid Tumor
- lorlatinib
- +4 more
-
Kettering, OhioKettering Health Network
Oct 14, 2022
Prostate Cancer Metastatic Trial in Boston (Telaglenastat, Talazoparib)
Not yet recruiting
- Prostate Cancer Metastatic
- Telaglenastat
- Talazoparib
-
Boston, MassachusettsMassachusetts General Hospital
Mar 27, 2021
Advanced Solid Tumors Trial in Worldwide (Talazoparib, Itraconazole, Rifampin)
Completed
- Advanced Solid Tumors
- Talazoparib
- +2 more
-
Budapest, Hungary
- +6 more
Jun 1, 2021
Pancytopenia Related to PARP Inhibitors (PancytoRIB)
Completed
- Cancer
- PARP inhibitor
-
Caen, Basse Normandie, FranceAlexandre Joachim
Sep 16, 2021
Childhood Solid Tumors Trial in Memphis (Talazoparib, Irinotecan, Temozolomide)
Completed
- Childhood Solid Tumors
- Talazoparib
- +4 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Feb 8, 2021
TNBC - Triple-Negative Breast Cancer Trial in Seoul (Talazoparib, Placebo)
Not yet recruiting
- TNBC - Triple-Negative Breast Cancer
- Talazoparib
- Placebo
-
Seoul, Korea, Republic ofYonsei University College of Medicine
Feb 14, 2021
Neuroendocrine Tumors Trial in Melbourne (Talazoparib)
Recruiting
- Neuroendocrine Tumors
- Talazoparib
-
Melbourne, Victoria, AustraliaPeter MacCallum Cancer Centre
Sep 20, 2021
Fallopian Tube Serous Adenocarcinoma, High Grade Ovarian Serous Adenocarcinoma, Ovarian Mass Trial in United States (Laboratory
Completed
- Fallopian Tube Serous Adenocarcinoma
- +18 more
- Laboratory Biomarker Analysis
- BMN 673
-
Houston, Texas
- +5 more
Feb 11, 2022
Pulmonary Toxicities Related to PARP Inhibitors (PulmonaRIB)
Recruiting
- Cancer
- olaparib, rucaparib, niraparib, talazoparib, veliparib, pamiparib
-
Caen, Basse Normandie, FranceAlexandre Joachim
May 27, 2021
Breast Cancer, Triple Negative Breast Cancer Trial in United States (Capecitabine, Talazoparib, Atezolizumab)
Recruiting
- Breast Cancer
- Triple Negative Breast Cancer
- Capecitabine
- +4 more
-
Washington, District of Columbia
- +5 more
Jan 12, 2023
Ovarian Cancer Trial in Worldwide (Chemotherapy + avelumab followed by avelumab + talazoparib, Chemotherapy followed by
Completed
- Ovarian Cancer
- Chemotherapy + avelumab followed by avelumab + talazoparib
- +2 more
-
Phoenix, Arizona
- +71 more
Jul 21, 2022
Locally Advanced or Metastatic Solid Tumors, Genes, BRCA 1 Trial in Worldwide (Avelumab, Talazoparib)
Active, not recruiting
- Locally Advanced or Metastatic Solid Tumors
- Genes, BRCA 1
- Avelumab
- Talazoparib
-
Palo Alto, California
- +89 more
Jan 18, 2023
Ovarian Cancer Trial run by the NCI (BMN 673 (talazoparib))
Terminated
- Ovarian Cancer
- BMN 673 (talazoparib)
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 5, 2020
Advanced Malignant Pleural or Peritoneal Mesothelioma Trial (Talazoparib)
Not yet recruiting
- Advanced Malignant Pleural or Peritoneal Mesothelioma
- Talazoparib
- (no location specified)
Jul 8, 2020
Advanced Ovarian Cancer, Primary Peritoneal Cancer, Advanced Breast Cancer Trial run by the NCI (BMN 673)
Completed
- Advanced Ovarian Cancer
- +3 more
- BMN 673
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Feb 2, 2021
Endometrial Cancer Trial in United States (Atezolizumab - 28 Day Cycle, Bevacizumab, Ipatasertib)
Recruiting
- Endometrial Cancer
- Atezolizumab - 28 Day Cycle
- +6 more
-
Duarte, California
- +13 more
Jun 8, 2022
Adult Solid Tumor, Childhood Solid Tumor, Recurrent Childhood CNS Tumor Trial in United States (Laboratory Biomarker Analysis,
Completed
- Adult Solid Neoplasm
- +5 more
- Laboratory Biomarker Analysis
- +3 more
-
Birmingham, Alabama
- +21 more
Mar 1, 2021